07:47 AM EST, 11/14/2025 (MT Newswires) -- Twist Bioscience ( TWST ) reported Friday a fiscal Q4 net loss of $0.45 per diluted share, narrower than a loss of $0.59 a year earlier.

Three analysts polled by FactSet expected a loss of $0.43.

Revenue for the quarter ended Sept. 30 was $99 million, up from $84.7 million a year earlier.

Analysts surveyed by FactSet expected $97.4 million.

The company said it expects total revenue for fiscal Q1 of 2026 of $100 million to $101 million. Analysts polled by FactSet expect $100.1 million.

For the full fiscal year 2026, the company said it expects total revenue of $425 million to $435 million. Analysts surveyed by FactSet expect $431.9 million.

The company's shares were down more than 9% in recent Friday premarket activity.